Search

Your search keyword '"Mann, H."' showing total 2,037 results

Search Constraints

Start Over You searched for: Author "Mann, H." Remove constraint Author: "Mann, H."
2,037 results on '"Mann, H."'

Search Results

1. A qualitative analysis exploring the use of Video Interaction Guidance within the context of supporting the development of succesful fostering relationships

2. AB0964 EFFICACY AND DRUG SURVIVAL OF IXEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS FROM THE CZECH BIOLOGICS REGISTRY ATTRA: IMPACT OF PRIOR SECUKINUMAB EXPOSURE

4. Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date

5. Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study

6. Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN

8. Towards a standardized framework for AI-assisted, image-based monitoring of nocturnal insects.

10. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis

11. VEXAS syndrom – diagnóza na pomezí revmatologie a hematologie.

12. Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

18. POS1226 CARDIOVASCULAR RISK IN PATIENTS WITH MYOSITIS COMPARED TO THE GENERAL POPULATION

20. Durvalumab (D)+/− tremelimumab (T)+chemotherapy (CT) in 1L metastatic (m) NSCLC: overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)

25. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

26. Le taux sérique des IgG2 anti-TIF 1γ est associé à la présence d’un cancer chez les adultes atteints de dermatomyosite

27. 326P Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)

28. 1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

29. EP08.01-042 NEPTUNE China Cohort: First-Line Durvalumab + Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC

30. LBA59 Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)

32. EP08.01-027 Durvalumab (D) ± Tremelimumab (T) + Chemotherapy (CT) in 1L Metastatic NSCLC: Outcomes by Tumour PD-L1 Expression in POSEIDON

33. Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery:a systematic review and international external validation cohort study

34. Comparison of cardiovascular risk in idiopathic inflammatory myopathy with general population – Preliminary data from a single-centre cross-sectional study

35. Holocaust memory and its mediation by teachers: a study of England and France (1987 - 2018)

38. OP0160 HLA-DRB1 ASSOCIATIONS WITH AUTOANTIBODY-DEFINED SUBGROUPS IN IDIOPATHIC INFLAMMATORY MYOPATHIES (IIM)

40. AB0678 Subclinical Atherosclerosis and Cardiovascular Risk in Myositis Patients and Healthy Controls: Preliminary Data From a Single-center Cross-sectional Study

41. 141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

42. 5MO Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDON

43. Automatic flower detection and phenology monitoring using time-lapse cameras and deep learning

44. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

45. Timing of nasogastric tube insertion and the risk of postoperative pneumonia: an international, prospective cohort study

Catalog

Books, media, physical & digital resources